Page last updated: 2024-08-24

tepoxalin and Cholera Infantum

tepoxalin has been researched along with Cholera Infantum in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Arnout, J; Baldauf, C; Brunner, F; Chow, A; De Broe, M; De Schepper, PJ; Depré, M; Jurgens, A; Pousset, V; Van Hecken, A; Verbesselt, R; Vermylen, J; Verpooten, GA	1

Trials

1 trial(s) available for tepoxalin and Cholera Infantum

Article	Year
Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man. International journal of clinical pharmacology research, 1996, Volume: 16, Issue:1 Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cyclooxygenase Inhibitors; Double-Blind Method; Gastrointestinal Diseases; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Thromboxane B2	1996

Article

Year

Biochemical activity, pharmacokinetics and tolerability of tepoxalin, a cyclooxygenase/5-lipoxygenase inhibitor, in man.

International journal of clinical pharmacology research, 1996, Volume: 16, Issue:1

Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Cyclooxygenase Inhibitors; Double-Blind Method; Gastrointestinal Diseases; Humans; Leukotriene B4; Lipoxygenase Inhibitors; Liver Function Tests; Male; Metabolic Clearance Rate; Middle Aged; Platelet Aggregation Inhibitors; Pyrazoles; Thromboxane B2

1996